Short excerpt
The coronavirus vaccine developed by Pfizer and BioNTech has proven a success. First to receive emergency use approval in the United States, the Pfizer shot has become the world’s most popular, with 3.5 billion purchased. Sales could double in 2022, according to projections. But the rapid proliferation of the vaccine, under contracts negotiated between the company and governments, has unfolded behind a veil of strict secrecy, allowing for little public scrutiny of Pfizer’s burgeoning power, even